# China Galaxy Securities

> China Galaxy Securities is a VC fund backing Manufacturing and Automotive. See 9 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 9
- Last investment: Feb 2026
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.chinastock.com.cn/

China Galaxy Securities is a VC fund in Beijing focused on Manufacturing and Automotive. China Galaxy Securities established on January 26, 2007 with a registered capital of RMB6 billion and a business scope covering securities brokerage, securities investment consulting, financial advisory for securities trading and securities investment, securities underwriting and sponsoring, securities proprietary trading and securities assetsmanagement. The promoters of their Company were Galaxy Financial Holdings, Beijing Tsinghua Venture Capital (currently known as Qingyuan Defeng), Chongqing Water, China General and CNBM. As of the date of establishment of their Company, Galaxy Financial Holdings contributed approximately RMB5,993 million to the registered capital of their Company and held approximately 99.89% of their Shares, while the other four promoters collectively contributed approximately RMB7 million of the registered capital of their Company and held approximately 0.11% of their Shares.

## Contacts

5 contacts available for China Galaxy Securities. Shizune tracks 4 team members at China Galaxy Securities. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/china-galaxy-securities?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 3 | 33% |
| Automotive | 2 | 22% |
| Health Care | 2 | 22% |
| News | 1 | 11% |
| Sales | 1 | 11% |

18 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Post-IPO Equity | 3 | 33% |
| Series B | 2 | 22% |
| Seed | 1 | 11% |
| Series A | 1 | 11% |
| Series C | 1 | 11% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 8 | 89% |
| United States | 1 | 11% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Guofang Wu | Chief Business Officer | 0 | — |
| Jianhui Wu | Chief Business Officer | 0 | — |
| Ruimin Zhu | Chief Financial Officer | 0 | — |
| Yanwu Yin | Chief Business Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Biyi Laser | Biyi Laser refers to a technology that uses laser beams as information carriers to directly transmit voice, data, and images at high speed and in a bidirectional manner, offering advantages such as high bandwidth, strong anti-interference capability, enhanced security, and flexible deployment for applications in communications, data transmission,and advanced information systems. |  | Seed | Feb 02, 2026 |  |
| Yundao Zhizao | Yundao Zhizao provides R&D simulation technology and the localization of simulation software. | $97.3M | Series C | Mar 05, 2024 |  |
| Boruspan Precision | Boruspan is a machine tool manufacturing enterprise, engaged in the R&D and manufacturing of high-precision CNC machine tools. | $36.3M | Series D | Apr 24, 2023 |  |
| Sokon | Chongqing Sokon Industry Group Stock Co.,Ltd. researches and develops, manufactures, sells, and services automobiles, and related engines and components in China and internationally. It offers small-displacement automotive powertrains and related systematic solutions; and seats, front and rear bumpers, interior parts, and shock absorber products. | $1.1B | Post-IPO Equity | Jul 16, 2022 |  |
| Singlera Genomics | Singlera Genomics is a fast growing company focusing on non-invasive genetic testing. Singlera’s main products and services include tumor diagnosis and personalized treatment, non-invasive prenatal diagnosis, pre-implantation genetic screening, and customized scientific research services. Singlera is dedicated to the development of precisionmedicine, striving to help the patients through early, accurate and informative diagnoses. | $44.9M | Series B | Jun 08, 2022 |  |
| Inspur Health | Inspur Health provides platform for storing medical data. | $14.3M | Series A | Feb 18, 2020 |  |
| Robotleo | Robotleo is focused on the research and development of intelligent companion robots for home use. |  | Series B | Apr 16, 2018 |  |
| Sinic-Tek | Sinic-Tek is the 3D non-destructive visual inspection system and equipment manufacturer in China. | $1.7M | Post-IPO Equity | Apr 06, 2017 |  |
| Tiexue.net | Tiexue.net is a military news media platform. | $19.6M | Post-IPO Equity | Feb 25, 2016 |  |

9 of 9 investments shown.

## Co-investors
- [CITIC Securities](https://shizune.co/investors/profile/citic-securities) — VC Fund, 3 deals together
- [Greater Bay Area Homeland Development Fund](https://shizune.co/investors/profile/greater-bay-area-homeland-development-fund) — VC Fund, 2 deals together
- Beijing Advanced Fund — VC Fund, 1 deal together
- Best — VC Fund, 1 deal together
- [CCB Trust](https://shizune.co/investors/profile/ccb-trust-co) — VC Fund, 1 deal together
- [China Merchants Securities](https://shizune.co/investors/profile/china-merchants-securities) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management) — VC Fund
- [KB Securities](https://shizune.co/investors/profile/kb-securities) — VC Fund
- [Frazier Healthcare Partners](https://shizune.co/investors/profile/frazier-healthcare-ventures) — VC Fund

## FAQ

### What does China Galaxy Securities invest in?

China Galaxy Securities invests primarily in Manufacturing, Automotive and Health Care startups, most often at Post-IPO Equity and Series B stage. Most of the 9 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact China Galaxy Securities?

Public channels for China Galaxy Securities include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at China Galaxy Securities?

The team at China Galaxy Securities includes Guofang Wu (Chief Business Officer), Jianhui Wu (Chief Business Officer) and Ruimin Zhu (Chief Financial Officer). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co